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Introduction
Neisseria meningitidis is an etiological factor of inva-
sive meningococcal disease (IMD), which is an acute, 
infectious illness characterized by a severe clinical 
course, even if antibiotics are administered at an early 
stage and intensive care is provided (Rosenstein et al. 
2001). This Gram-negative diplococcus colonizes the 
nasopharyngeal mucosa and is transmitted from person 
to person via droplets or through a direct physical con-
tact with secretions of infected patients or asymptomatic 
carriers, who account for 5–10% of the general popula-
tion (Soriano-Gabarro et al. 2011). It is estimated, that 
carriage rates of N. meningitidis in closed environments 
(dormitories, military units) may be significantly higher 
and reach > 40% (Tyski et al. 2000). Until now, twelve 
meningococcal serogroups have been described (they 
are distinguished according to biochemical constitution 
of the polysaccharide capsules of bacteria). The groups 
of N. meningitidis mostly associated with IMD are A, B, 
C, W and Y (Skoczyńska and Hryniewicz 2012). Sero-
group incidence varies depending on the geographical 
area (Jafri et al. 2013). Groups B and C are a main cause 
of IMD in Americas and Europe. It is estimated that 
there are 1.2 million new IMD cases worldwide every 
year, with mortality reaching 10% or even 70% in cases 
of a septic shock (Rosenstein et al. 2001). In Poland, 
IMD incidence was found to be 0.43/100 000 in 2016 
and 0.58/100 000 in 2017 (NIZP-PZH 2018). IMD cases 
have also been reported among the Polish military per-
sonnel: four cases in the military base in Skwierzyna, 
including two deaths in 2006 (Grecki and Bienias 2006), 
15 cases in a  military base in Warsaw, including two 
deaths in 2007 (Kadłubowski et al. 2007), and one death 
from IMD in the Polish Military Contingent in Afghani-
stan (Konior and Korzeniewski 2016). The incidence of 
IMD in US military personnel, historically far above that 
in the general population, has decreased > 90% since in 
early 1970s, when the first vaccine against meningo-
coccal infections was introduced (Broderick et al. 2015). 
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A b s t r a c t
Neisseria meningitidis is an etiological factor of invasive meningococcal disease (IMD). This Gram-negative diplococcus is transmitted from 
person to person via droplets or through a direct physical contact with secretions of infected patients or asymptomatic carriers. The latter 
account for 5–10% of the general population. The aim of the study was to estimate the actual N. meningitidis carriage rate in the military 
environment with identification of serogroups, genogroups, sequence types and clonal complexes of the isolates detected among Polish sol-
diers. The study was conducted during winter seasons of 2015 and 2016 and involved 883 professional soldiers from the Armoured Brigade 
in Świętoszów, Poland. The material for testing were nasopharyngeal swabs obtained from study participants. The samples were tested using 
standard microbiological methods (culture, incubation, microscopy, biochemical and automated identification). N. meningitidis isolates were 
subjected to slide agglutination test (identification of serogroups), the bacterial DNA was extracted and allowed to determine genogroups, 
clonal complexes and sequence types. 76 soldiers were found to be carriers of N. meningitidis, they accounted for 8.6% of the study group. 
The meningococcal isolates mostly belonged to serogroup B. Sequence types ST-11439, ST-136, ST-1136 and the clonal complex 41/44CC 
were found to be predominant. Clonal complexes responsible for IMD were detected in 15.8% of carriers and 1.4% of the whole study 
participants. Carriage rates of N. meningitidis among Polish soldiers were found to be similar to those reported in the general population.
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Over the last decade, incidences of IMD in the military 
and US general population have become equivalent 
(Brode rick et al. 2012).
Meningococcal carriage studies conducted among 
European conscripts over the last several decades dem-
onstrated high carriage incidence, often exceeding 30%. 
The studies by Tyski et al. (2001) carried out in the last 
decade of the 20th century revealed that N. meningitidis 
carriage incidence among Polish conscripts was 60%. 
However, in 2009 Poland suspended conscription and 
transformed its national army into a fully professional 
organization. Recruits have been replaced by pro- 
fessional soldiers, whose socio-demographic profile 
as well as the character of work/service they perform 
is different from that of young conscripts who used to 
serve on a 24/7 basis and were permanently assigned 
to a given military facility. The first study presenting the 
general prevalence of N. meningitidis carriage in pro-
fessional soldiers in Poland was conducted in winter 
season of 2016. The overall carrier rate among 1246 
soldiers from the Armoured Brigade amounted to 5.2% 
(single examination), with the serogroup B being pre-
dominant (Korzeniewski et al. 2017).
The aim of the present study was to estimate the 
actual N. meningitidis carriage rate in the military envi-
ronment with identification of serogroups, genogroups, 
sequence types and clonal complexes of the isolates 
(including clonal complexes responsible for IMD) 
detected among Polish soldiers.
Experimental
Materials and Methods
Study population. A total of 1766 biological sam-
ples from nasopharyngeal mucosa were taken from 
883 professional soldiers serving in the 10th Armoured 
Brigade in Świętoszów, Poland (the first sample was 
collected in 2015, the second in 2016 from the same 
individual). The soldiers were joining the study group 
during the winter season (January–March); all of the 
participants had to provide informed consent and 
complete a socio-demographic and behavioral ques-
tionnaire including information on their military rank, 
age, sex, place of residence, cigarette smoking, medica-
tions taken on a regular basis, and vaccinations received 
against meningococcal serogroups A, C, W-135, Y (18% 
of examined soldiers were vaccinated between 2008 and 
2014). Only professional soldiers, men or women aged 
21–59 years (median 31 years), with 1–26 years of mili-
tary service, in a good health condition were involved 
in the study. Soldiers with any anatomical or pathologi-
cal lesions in the nasopharynx, which could prevent the 
collection of samples were excluded from the study.
Ethical Procedure. A research task was approved by 
the Ethics Committee of the Military Institute of Medi-
cine in Warsaw, Poland (Decision No. 24/WIM/2014 of 
18 Aug 2014).
Identification of isolates. The specimens obtained 
from the nasopharynx were transported to the micro-
biological laboratory in the Military Institute of Medi-
cine, Warsaw, where they were plated onto the appro-
priate medium, i.e. Columbia Agar with 5% sheep blood 
and PoliVitex VCA3 and incubated under elevated CO2 
concentration at 37°C for 48 hours. After incubation, 
the colonies grown were macroscopically evaluated. 
Colonies morphologically similar to N. meningitidis 
phenotypes were isolated onto Columbia Agar with 
5% sheep blood and were incubated under elevated 
CO2 concentration at 37°C for 24 hours. The incubated 
pure colonies of bacteria were used to prepare Gram-
stained preparations, which were then observed under 
a light microscope. Catalase and cytochrome oxidase 
tests were performed. All Gram-negative strains were 
identified based on their biochemical features using 
Vitek 2 NH card. The strains identified as N. meningi­
tidis were stored frozen in a temperature of –20°C and 
then transported to the National Reference Center for 
the Diagnostics of Bacterial Infections of the Central 
Nervous System (KOROUN) in Warsaw, Poland for 
further diagnostics.
Serogrouping. The strains delivered to KOROUN 
were revived by placing them onto Columbia Agar 
medium; they were incubated in elevated CO2 atmos-
phere at 37°C for 24 hours. Serogroups of all isolates 
were identified with a slide agglutination test using 
a set of primers in compliance with the manufacturer’s 
instructions (detection of capsular antigens of N. menin­
gitidis). The specific reagents covered the following 
serogroups: A, B, C, Y and W (Remel), E29 (Bio-Rad), 
X and Z (Becton Dickinson). Typing was performed 
on colonies isolated from the Mueller-Hinton agar 
medium following the identification of the strains.
Genogrouping. Chromosomal DNA was isolated 
from meningococcal isolates with Genomic DNA 
Prep Plus (A&A Biotechnology) following the manu-
facturer’s recommendations. Genogroups were iden-
tified with the PCR assay using genogroup-specific 
oligonucleotide primers orf­2(A), siaD(C), siaD(W135) 
and siaD(Y) described by Taha (2000) and siaD(B) 
described by Guiver et al. (2000). The products were 
analyzed on the agarose gel. Genogroups A, B, C, E29, 
W, Y were identified.
Sequencing. Sequencing was performed on seven 
DNA fragments of the isolated strains. The chromato-
grams were analyzed using the Seqed 10.3 programme 
(Applied Biosystems) and the sequences obtained from 
the specimens were compared with the sequences avail-
able in the international database (http://pubmlst.org/
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neisseria/). Individual loci were assigned to the right 
alleles. We identified the sequence type (ST) and clonal 
complex (CC) of the isolates which had a complete 
allelic profile (seven loci). In the case of isolates whose 
allelic profile was incomplete, only the clonal complex 
was identified.
Statistics. Statistical analysis was performed using 
STATISTICA PL version 12.0 and Microsoft Excel 2013. 
The quantitative variables were counted by arithmetic 
mean ± SD or median and 95% confidence interval. 
The qualitative variables were introduced in the abso-
lute or percentage terms. Significance of differences 
between two groups was processed with the t-Student 
or U Mann-Whitney test. In all the calculations p-value 
under 0.05 was considered statistically significant.
Results
A nasopharyngeal culture sample was collected twice 
during winter seasons (in 2015 and then in 2016) from 
883 soldiers. 76 of the subjects tested were found to be 
carriers (at least one of the single samples collected in 
2015 and 2016 was positive for N. meningitidis); the car-
riers accounted for 8.6% of the study group. In 2015, 
genogroups were determined for 46 isolates: B (n = 33, 
61.1%), E29 (n = 6, 11.1%), C (n = 4, 7.4%), Y (n = 2, 3.7%), 
W (n = 1, 1.9%). Eight isolates were non-groupable (NG, 
14.8%) with the primers used. In 2016, genogroups were 
determined for 46 isolates: B (n = 24, 45.3%), E29 (n = 8, 
15.1%), C  (n = 6, 11.3%), Y  (n = 6, 11.3%), W  (n = 2, 
3.8%); genogroups of 7 isolates (NG, 13.2%) could not 
be determined with the primers used (Fig. 1).
Based on the MLST analysis, 21 different sequence 
types were identified among the isolates analyzed. 
Although the analysis was repeated several times, the 
sequence type and clonal complex of one of the isolates 
of genogroup B could not be determined in 2016. In 
both studies, 12 clonal complexes (CC) were identified 
among 62 N. meningitidis strains (25 isolates were iden-
tical to each other in both years, 12 were isolated once 
only). The most common clonal complexes included: 
41/44CC (n = 6), 1136CC (n = 2), 53CC (n = 2). Only 
five strains which were found in both studies (in 2015 
and again in 2016) and two strains isolated in 2016 were 
not assigned to any clonal complex. In six carriers the 
authors observed a change in the sequence type at the 
second collection and in four carriers also a change in 
the clonal complex. In one carrier genogroup B was 
found at the first collection and was replaced by geno-
group Y at the second collection (Table I).
The mean age of N. meningitidis carriers in the study 
group was 30.4 ± 4.7 years and of non-carriers it was 
32.1 ± 5.3 years. Carriers were significantly younger 
(p = 0.0083). No statistically significant differences were 
found between carriage prevalence and sex or resi-
dence. There were significantly more tobacco smokers 
among N. meningitidis carriers than in the non-carrier 
group (51.3% vs. 32.8%; p = 0.0012). The distribution of 
military ranks in both groups (carriers vs. non-carriers) 
was found to be statistically significant (p = 0.0088), the 
corps of privates being the largest. There were no statis-
tically significant differences between carrier state and 
prior vaccination against N. meningitidis (Table II).
Discussion
N. meningitidis, the etiological factor of invasive 
meningococcal disease (IMD), can be the cause of 
meningitis and/or sepsis. In most cases, meningococ-
cal carriage does not lead to invasive disease, but is lim-
ited to asymptomatic carrier state which is normally 
found in 5–10% of the general population (Tzeng and 
Fig. 1. Percentage distribution of N. meningitidis genogroups among Polish soldiers tested in years 2015–2016.
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Table I
Distribution of sequence types (ST), clonal complexes and genogroups
of the N. meningitidis isolates tested in years 2015–2016.
ST 2015 Clonal complex 2015 ST 2016 Clonal complex 2016
Genogrup B
  136 ST-41/44 complex/Lineage 3   136 ST-41/44 complex/Lineage 3
  136    136 
  136    136 
 1097   1097 
 2840   2840 
11442   8107 ST-213 complex
 1732  negative negative
  112  negative negative
  973  negative negative
   35 ST-35 complex    35 ST-35 complex
   35  negative negative
   35  negative negative
   35  negative negative
  162 ST-162 complex   162 ST-162 complex
  162   4509 –
  162  negative negative
  162  negative negative
11433 ST-213 complex 11433 ST-213 complex
  213  negative negative
   33 ST-32 complex negative negative
   33  negative negative
   32  negative negative
11440 ST-1136 complex 11440 ST-1136 complex
 2126 ST-53 complex  2126 ST-53 complex
  198 ST-198 complex   198 ST-198 complex
 1001 ST-18 complex 11446 –
11436 ST-364 complex negative negative
 5133 ST-103 complex negative negative
 9316   9316 –
 1572   1572 –
11444  negative negative
11447  negative negative
negative negative    35 ST-35 complex
negative negative 11436 ST-364 complex
negative negative    36 –
negative negative 12187 –
negative negative  9157 –
negative negative 12186 –
negative negative   120 –
negative negative undetermined1 undetermined1
Genogrup E29
11434 ST-254 complex 11434 ST-254 complex
11438  11438 –
 1138 ST-60 complex  1138 ST-60 complex
11439  11439 –
11439  11439 –
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Stephens 2000). In Poland, there have been reports of 
IMD cases in recent years; however, the actual carriage 
incidence of N. meningitidis among Polish residents has 
not been determined (Jafri et al. 2013). Many of Pol-
ish and European publications on the N. meningitidis 
carriage incidence are limited to military environment 
(Chapalain et al. 1992; Tyski et al. 2000; Korzeniewski 
et al. 2015). According to the research findings, menin-
gococcal carriage is high among conscripted soldiers 
serving in European armies, whereas among profes-
sional soldiers it was found to be like the carriage rates 
observed in the general population (Korzeniewski 
et al. 2017). Meningococcal carriage studies conducted 
among military personnel also revealed that serogroup 
B was the most prevalent (Taha 2000). In Denmark, 
43% of newly drafted recruits were found to be carriers 
of N. meningitidis, of whom 34% were transient carriers 
(this was associated with the colonization variability in 
the nasopharyngeal mucosa); 34% of the strains isolated 
from carriers belonged to serogroup B (Andersen et al. 
1 Sequence type and clonal complex could not be determined
2 Genogroup B was identified in the first collection and genogroup Y was detected in the second collection
Table I continued
ST 2015 Clonal complex 2015 ST 2016 Clonal complex 2016
11445 ST-60 complex negative negative
negative negative  1157 ST-1157 complex
negative negative    60 ST-60 complex
negative negative 11438 ST-11438 complex
Genogrup C
 2433 ST-41/44 complex/Lineage 3  2433 ST-41/44 complex/Lineage 3
 2003 –  2003 –
 5238 – negative negative
 5133 ST-103 complex negative negative
negative negative  3346 ST-41/44 complex/Lineage 3
negative negative  3346
negative negative  2433
negative negative  8108 ST-174 complex
Genogrup Y
  767 ST-167 complex   767 ST-167 complex
 9316 –  9316 –
negative negative   767 ST-167 complex
negative negative   767
negative negative  3342 ST-865 compex
Genogrup W
  112 ST-41/44 complex/Lineage 3   112 ST-41/44 complex/Lineage 3
negative negative    22 ST-22 complex
NG
 9268 ST-53 complex  9268 ST-53 complex
10159     53
   53  negative negative
 1136 ST-1136 complex  1136 ST-1136 complex
 1136  negative negative
  198 ST-198 complex negative negative
  198  negative negative
11441 ST-364 complex 11441 ST-364 complex
negative negative  4431 ST-41/44 complex/Lineage 3
negative negative  3461
negative negative  9466
Genogrup B / Genogrup Y2
11437 ST-41/44 complex/Lineage 3    92 ST-92 complex
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1998). The study, which was conducted in six military 
camps in Bavaria, found that 32% of the soldiers tested 
were carriers of N. meningitidis, and serogroup B was 
identified in 42% of them (Claus et al. 2005). Excep-
tionally high rates of meningococcal carriage, over 70%, 
were observed among British and Norwegian recruits, 
in whom serogroup B was also the most commonly 
found (Fraser et al. 1973; Caugant et al. 1992). There 
have been very few meningococcal carriage surveillance 
studies outside Europe. One of such studies, with the 
participation of Iranian soldiers, demonstrated that 
the incidence of N. meningitidis carriage among newly 
drafted soldiers was 11%, but after 2 months of ser-
vice it increased to 33%. The study also revealed that 
serogroup  B was predominant among the recruits 
tested (Eslami-Nejad et al. 2005). A study involving 
Iranian recruits which was performed a decade later 
demonstrated a lower carriage rate (8%), with a domi-
nance of serogroup C (Ataee et al. 2016). A research 
study into Polish recruits carried out between 1998 
and 1999 demonstrated meningococcal carriage rate 
at 31%, with the predominance of serogroup B (Tyski 
et al. 1998; Tyski et al. 2000). The first meningococcal 
carriage study in Polish professional soldiers (n = 559), 
which was conducted in 2013, showed the incidence 
of N. meningitidis carriage at 5.7% (Korzeniewski et al. 
2015). A significant factor contributing to a reduction 
in meningococcal carriage incidence in the military 
environment was a change in the character of mili-
tary service after the Polish Armed Forces have been 
transformed into a professional organization. Recruits 
used to serve on a 24/7 basis, they were permanently 
accommodated in the barracks and had all their meals 
in military dining facilities. Professional soldiers, on 
the other hand, typically work 8 hours a day and they 
are accommodated outside the military facilities (pro-
fessional military service has changed to a  regular 
job, with risk factors similar to those observed in the 
civilian environment). Another factor contributing to 
decreasing of meningococcal carriage prevalence was 
raise of the age of soldiers (19–20 year old recruits vs. 
professional privates who usually begin their military 
career at the age of 25–30  years old) (Korzeniewski 
et al. 2017). Meningococcal vaccination may also have 
a positive impact on reducing carriage prevalence of 
N. meningitidis and lowering the number of new IMD 
Age   0.0083
Mean (SD) 32.1 (5.3) 30.4 (4.7) 
Range 21.0–59.0 23.0–45.0 
Median 31.0 30.0 
Sex   0.6490
Women 65 (8.1%) 5 (6.6%) 
Men 742 (91.9%) 71 (93.4%) 
Place of residence   0.3318
Rural area 322 (39.9%) 26 (34.2%) 
Urban area 485 (60.1%) 50 (65.8%) 
Smoking cigarettes   0.0012
Yes 265 (32.8%) 39 (51.3%) 
No 542 (67.2%) 37 (48.7%) 
Respiratory tract infection   0.1106
Yes 61 (7.6%) 2 (2.6%) 
No 746 (92.4%) 74 (97.4%) 
Military rank   0.0088
Private 479 (59.4%) 57 (75.0%) 
Non-commissioned officer 276 (34.2%) 19 (25.0%) 
Officer 52 (6.4%) 0 (0.0%) 
Vaccination   0.1567
Yes 148 (18.3%) 9 (11.8%)
No 659 (81.7%) 67 (88.2%)
Table II 
Socio-demografic variables between control group (non-carriers) and carriers of N. meningitidis
in years 2015–2016.
Socio-demographic
variables
Control group
(non-carriers n = 807)
Carriers
(n = 76) p-value
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cases; however, its effectiveness varies depending on the 
type of vaccine used, with conjugate vaccines being 
the most effective (Decker 2016). It needs to be pointed 
out that meningococcal vaccination does not com-
pletely prevent individuals from acquiring an infection, 
e.g. cases of the disease were reported among French 
soldiers, despite the use of immunoprophylaxis (Duron 
et al. 2016). The studies with the participation of Polish 
military personnel demonstrated that meningococ-
cal carriage incidence was lower in older soldiers; the 
results are consistent with the available research find-
ings (Taha 2000; Tzeng and Stephens 2000; Caugant 
et al. 2009; Soriano-Gabarro et al. 2011). Another fac-
tor associated with an increased risk for meningococcal 
carriage was found to be tobacco smoking (Blackwell 
et al. 1990; Caugant et al. 1992; Korzeniewski et al. 
2017). The studies by Caugant et al. (1988) demon-
strated that hypervirulent N. meningitidis strains rarely 
colonize the nasopharyngeal mucosa of carriers. The 
present study, and especially the application of sequenc-
ing methods, has proved to be useful in determining 
the genetic relationship among different strains and 
estimating the risk for IMD among carriers. The study 
involving Polish soldiers found virulent strains in 15.8% 
of carriers (n = 76) and 1.4% of the whole study group 
(n = 883). Stephens (1999) estimated that the risk of 
developing IMD by people living in closed environ-
ments is 1–1.5%. The incidence of specific clonal com-
plexes is associated with the dominance of individual 
serogroups (Trotter et al. 2007; Jandova et al. 2016). In 
Poland serogroup B, comprising ST-32CC, ST-18CC, 
ST-41/44CC, ST-213CC and ST-269, was found to 
be predominant. Serogroup  C covers ST-103CC, 
ST-41/44CC and ST-11CC. Serogroup W is repre-
sented by ST-22CC, and Y by ST-22CC, ST-23CC, 
ST-92CC, ST-167CC (Skoczyńska et al. 2013; Waśko 
et al. 2015). The present study confirmed that serogroup 
B was predominant among carriers; it was mostly repre-
sented by ST-41/44CC. Similar sequencing results were 
observed in Greece in a population of military recruits 
(Tryfinopoulou et al. 2016). Hypervirulent clonal com-
plexes ST-213CC, ST-213CC, which have been observed 
in Poland, were also found in the study partici pants. 
Among serogroup C isolates the most common were 
clonal complexes ST-41/44CC and ST-103CC. Sero-
group C was the third most common, after serogroup B 
and E29. Serogroup E29 was represented by the clonal 
complex ST-254CC and ST-60CC. At present, there is 
no data available concerning IMD morbidity from this 
particular serogroup (PubMLST, 2018). Serogroup Y 
covered the virulent clonal complex ST-167CC and 
once – ST-92CC. In this study, among carriers of sero-
group W the clonal complex ST-22CC was identified, 
which was listed by the National Reference Center 
for the Diagnostics of Bacterial Infections of Central 
Nervous System in Warsaw as the strain responsible 
for causing IMD cases in Poland (Skoczyńska et al. 
2013). In this current study, the hyperepidemic and 
hypervirulent strain ST-11 has not been identified. This 
strain is rarely found in carriers, its carriage is usually 
transient as the strain is rapidly transmitted to other 
hosts (Moxon and Jansen 2005). In general, there are 
significant differences in the incidence of the clonal 
complexes causing IMD and those responsible for 
meningococcal carriage (Caugant et al. 2007). Studies 
aimed at detecting pathogenic strains have been found 
to be valuable in determination of transmission routes, 
the distribution of individual genogroups and the epi-
demiological variability of N. meningitidis. While the 
surveillance of circulating strains is useful in selecting 
the best immunoprophylaxis (Millar et al. 2016).
Conclusions
The overall carriage rates and types of serogroups of 
N. meningitidis among Polish professional soldiers were 
similar to the carriage reported in the general popu-
lation. Clonal complexes responsible for IMD were 
detected in 15.8% of carriers and 1.4% of the whole 
study participants. Meningococcal carriage in profes-
sional soldiers was largely associated with a younger 
age, low military rank and frequent tobacco smoking.
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